Approval · Notice of Compliance 12805 · 2011
CALDOLOR: Notice of Compliance 12805
Issued November 29, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12805
- Date
- November 29, 2011
- Company
- Alveda Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Nonselective Cyclooxygenase Inhibitor / Nonsteroidal Anti-inflammatory Drug
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CALDOLOR | 02376857 | Dormant |
Medicinal ingredients
- IBUPROFEN 100 MG per ML